Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 51 - 60 of 243
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Concept Foundation, Sun Pharmaceuticals, India, WHO HRP, PT. Tunggal Idaman Abdi
Project Stage: SRA/WHO PQ Approved
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: DKT International, PT Harsen
Project Stage: Marketed
Alternative Name: K4K20S4
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Vaginal, Other, Other
Project Stage: Lead Optimization
Active Status: No
User: Male
Mode: Yes
Delivery Type: Oral, Subdermal
Developer: University of Edinburgh
Project Stage: Phase II
Alternative Name: DVD2
Active Status: No
User: Female
Mode: No
Delivery Type: Vaginal, Other
Developer: FHI 360
Project Stage: Phase I
Alternative Name: DMAU
Active Status: Yes
User: Male
Mode: Yes
Developer: BIOQUAL, Inc., NICHD, University of California at Los Angeles
Project Stage: Phase I
Alternative Name: Depot Medroxyprogesterone Acetate (DMPA) + Testosterone
Active Status: No
User: Male
Mode: Yes
Delivery Type: Injectable, Subdermal
Developer: ANZAC Research Institute
Project Stage: Phase I
Active Status: No
User: Male
Mode: Yes
Delivery Type: Injectable
Developer: National Research Institute for Family Planning in Beijing
Alternative Name: Plasma Membrane Calcium ATPase (PMCA) Inhibitors
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Vaginal Gel, Vaginal, Other
Developer: University of Manchester, Max Planck Institute
Role in reproduction: Sperm Function
Alternative Name: Dapivirine (DPV) + levonorgestrel (LNG) vaginal ring
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Vaginal Ring
Developer: International Partnership for Microbicides, USAID
Project Stage: Phase I

Pages

CSV